SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as investors weigh the potential for a "sell the news" event surrounding the upcoming Cybercab launch, with debate focused on whether the event will offer concrete commercialization timelines or underperform expectations. While bullish sentiment highlights the stock's recent momentum and strong options flow, many traders remain skeptical of the event's execution and potential for a post-launch pullback.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares plummeted after the company reported weak quarterly sales and issued a significant downward revision to its full-year revenue and earnings outlook. Traders are expressing widespread frustration over the company's brand direction and product quality, with many comparing its decline to recent struggles at Nike while debating whether the stock's sharp sell-off represents a value opportunity or a continued downward trend.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending due to a combination of negative retail sentiment following a decline in share price and ongoing speculation regarding potential S&P 500 inclusion. Traders are expressing frustration over the stock's underperformance compared to other fintech peers, while also debating the long-term impact of its recent strategic partnership with Payward to integrate banking and crypto services.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as traders speculate on the company's upcoming earnings, with significant debate over its growth prospects and the impact of its AI initiatives. While some community members anticipate a short squeeze given the high short interest, others express skepticism about its valuation and long-term trajectory.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Conversation regarding DJT is dominated by intense partisan political debate, with traders highlighting concerns over geopolitical tensions, military involvement in the Middle East, and the administration's economic policies. The discourse frequently touches on speculative rumors, personal character attacks, and social commentary rather than specific company fundamentals.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler is experiencing high volatility as traders debate the company's valuation following recent fiscal guidance that signaled slowing organic growth. While some investors remain optimistic about the long-term potential for its zero-trust platform, others are concerned about management's communication and the stock's underperformance relative to other cybersecurity peers.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is receiving attention following a double beat on second-quarter financial results, where the company reported record revenue and positive non-GAAP earnings. While the broader community sentiment remains bullish on the company's backlog and growth, discussion is tempered by concern over soft third-quarter guidance and ongoing volatility within the space sector.

Samsara, Inc. develops internet connected sensor systems. It combines plug-and-play sensors, wireless connectivity, and cloud-hosted software integrated for deployment. The company was founded by John Bicket and Sanjit Biswas in 2015 and is headquartered in San Francisco, CA.

Samsara Inc - Ordinary Shares - Class A

Samsara Inc

Samsara shares are receiving significant attention following a strong quarterly earnings report that featured both revenue and earnings beats, alongside a raised full-year outlook. While some traders express caution regarding decelerating growth rates and the company's reliance on large, unpredictable enterprise deals, the community remains largely focused on the company's long-term potential in physical AI and its data-driven competitive moat.

Ambarella, Inc. engages in the development of low-power system-on-a-chip (SoC), semiconductors, and software for edge artificial intelligence (AI) applications and intelligent automation. The firm's products include video security, advanced driver assistance (ADAS), electronic mirror, drive recorder, driver or cabin monitoring, autonomous driving, and other robotics applications. It operates through the following geographical segments: Taiwan, Asia Pacific, Europe, North America, and United States. The company was founded by Feng Ming Wang and Leslie D. Kohn on January 15, 2004 and is headquartered in Santa Clara, CA.

Ambarella Inc

Ambarella shares are currently trending as investors react to a mixed fiscal second-quarter earnings report, where a revenue and adjusted EPS beat was offset by margin pressure and cautious guidance. Traders are actively debating the company's long-term potential as a physical AI and robotics play versus concerns over rising supply-chain costs and the lack of a near-term revenue breakthrough.

DocuSign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign anything. The firm automates manual and paper-based processes allowing users to manage all aspects of documented business transactions including identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation, and storage. Its products include eSignature, CLM, Gen for Salesforce, Document Generation, Standards-Based Signatures, Notary and Web Forms. The company was founded by Thomas H. Gonser and Court Lorenzini in 2003 and is headquartered in San Francisco, CA.

DocuSign Inc

DocuSign is receiving significant attention as traders debate the long-term viability of the company amid concerns that AI-powered solutions, such as free e-sign tools, could commoditize its core business. While bulls point to positive earnings, a $2 billion buyback program, and AI-driven growth in Intelligent Agreement Management (IAM), bears maintain that the company faces stiff competition and declining relevance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IBRX the FDA seems perfectly content to allow Saudi Arabia to be the world&#39;s number one Center for treating bladder cancer and the checkpoint inhibitor failed lung cancer. The FDA has no excuse to not have approved anktiva for lymphopenia and papillary bladder cancer which it refused last year in 2025 in the refusal to file letter. Their game is obvious. Slow walk ibrx as long as they can to allow big farmer to either acquire or develop something in the family of antiva so they can save their profits. Nothing could be more obvious. Last year PSS had a meeting with Dr makary and he  ended the conversation in 10 minutes and didn&#39;t want to talk anymore. That&#39;s all you need to know about him. Until I see otherwise he is nothing but a big mouth for the benefit of big Pharma.

Lindzcav

FishOn

Tom Gjona

cyberInvest

Nate

John

Trina Aguirre

Kerrie anne Hopkins

Rich Rellihen

Duro Calie

Dr. O

Bsolar

Redoak

BUY N HOLD IS DEAD

Joop Lang

E.B. Matlack

Terry Manziano

Heg Grudson

Carolynnn

mine

Paul Cho

Don Smith

froggy

zaltenbairt

RTPaeschke

StockTwits Web

ImmunityBio Inc

 the FDA seems perfectly content to allow Saudi Arabia to be the world's number one Center for treating bladder cancer and the checkpoint inhibitor failed lung cancer. The FDA has no excuse to not have approved anktiva for lymphopenia and papillary bladder cancer which it refused last year in 2025 in the refusal to file letter. Their game is obvious. Slow walk ibrx as long as they can to allow big farmer to either acquire or develop something in the family of antiva so they can save their profits. Nothing could be more obvious. Last year PSS had a meeting with Dr makary and he  ended the conversation in 10 minutes and didn't want to talk anymore. That's all you need to know about him. Until I see otherwise he is nothing but a big mouth for the benefit of big Pharma.

Ben Son

Excuse the typos this is voice to text.big pharma not big farma.lol.

Excuse the typos this is voice to text.big pharma not big 

@Whatever2020 100% Correct, they must approve both, it&#39;s a slap in the face of all patients it has not happened already.

go ibrx
go PSS

StockTwits For Android 

 100% Correct, they must approve both, it's a slap in the face of all patients it has not happened already.

go ibrx
go PSS

@Trijack it&#39;s amazing how people can look at the trajectory of Anktiva, the trials, the safety profile and the efficacy and not understand that the denials have come because of bias, whether it&#39;s political personal or otherwise.

 it's amazing how people can look at the trajectory of Anktiva, the trials, the safety profile and the efficacy and not understand that the denials have come because of bias, whether it's political personal or otherwise.

@Whatever2020 be careful of big farmers.  They are full of crop.

Steven Duncan

 be careful of big farmers.  They are full of crop.